Old Web
English
Sign In
Acemap
>
authorDetail
>
H. S. Rasmussen
H. S. Rasmussen
Medicine
Matrix metalloproteinase inhibitor
Antiarrhythmic agent
Ventricular tachycardia
Class III antiarrhythmic agent
4
Papers
313
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Role of Metalloprotease Inhibitors in Cancer and Chronic Inflammatory Diseases
2000
Handbook of experimental pharmacology
H. S. Rasmussen
K. P. Lynch
Show All
Source
Cite
Save
Citations (0)
High pressure treatment of foods
1998
H. S. Rasmussen
Show All
Source
Cite
Save
Citations (0)
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
1998
Journal of Clinical Oncology
Slawomir Wojtowicz-Praga
Jeffrey A. Torri
Michael D. Johnson
V. Steen
John L. Marshall
Elizabeth Ness
Robert B. Dickson
M. Sale
H. S. Rasmussen
T A Chiodo
Michael J. Hawkins
Show All
Source
Cite
Save
Citations (230)
Dofetilide, A Novel Class Iii Antiarrhythmic Agent
1992
Journal of Cardiovascular Pharmacology
H. S. Rasmussen
M.J. Allen
K. J. Blackburn
Ghazwan Butrous
H.W. Dalrymple
Show All
Source
Cite
Save
Citations (83)
1